Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data

Pharmacogenomics. 2018 Feb;19(3):227-241. doi: 10.2217/pgs-2017-0101. Epub 2017 Dec 14.

Abstract

Aim: Adverse drug reactions to 5-Fluorouracil(5-FU) is frequent and largely attributable to genetic variations in the DPYD gene, a rate limiting enzyme that clears 5-FU. The study aims at understanding the pharmacogenetic landscape of DPYD variants in south Asian populations.

Materials & methods: Systematic analysis of population scale genome wide datasets of over 3000 south Asians was performed. Independent evaluation was performed in a small cohort of patients.

Results: Our analysis revealed significant differences in the the allelic distribution of variants in different ethnicities.

Conclusions: This is the first and largest genetic map the DPYD variants associated with adverse drug reaction to 5-FU in south Asian population. Our study highlights ethnic differences in allelic frequencies.

Keywords: 5-FU toxicity; DPYD; allele frequency; drug-related side effects and adverse reactions; pharmacogenomics; south Asia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / toxicity*
  • Asian People / genetics
  • Cohort Studies
  • Dihydrouracil Dehydrogenase (NADP) / genetics*
  • Drug-Related Side Effects and Adverse Reactions / enzymology
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Drug-Related Side Effects and Adverse Reactions / genetics*
  • Female
  • Fluorouracil / toxicity*
  • Gene Frequency
  • Humans
  • Male
  • Middle Aged
  • Pharmacogenetics*
  • Polymorphism, Single Nucleotide*
  • White People / genetics
  • Young Adult

Substances

  • Antimetabolites, Antineoplastic
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil